FTC Investigates Major Pharmacy Benefit Managers for Effects on Prescription Drug Market
On Tuesday, the Federal Trade Commission (FTC) announced that they were launching an inquiry into six pharmacy benefit managers: CVS Caremark; Express
Stay updated with breaking news from Scripts Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On Tuesday, the Federal Trade Commission (FTC) announced that they were launching an inquiry into six pharmacy benefit managers: CVS Caremark; Express
After years of pleading, the Federal Trade Commission on Tuesday voted to investigate the practices of some of the nation's largest health care companies. The companies are accused of using their dominance in myriad sectors of the health care space to drive up costs, drive out competition and reap profits.
All the hits—and let’s be honest . . . mostly inflation and its staying power—from Treasury Secretary Yellen’s trip to the Hill on Tuesday, including admissions that her and Chair...
WOONSOCKET (dpa-AFX) - The Federal Trade Commission or FTC said it will inquire into the prescription drug middlemen industry. The inquiry will scrutinize the impact of vertically integrated pharmacy
The pharmacy benefit managers will have 90 days to respond to the FTC's request for records and other information about their business practices.